Mutations in VPS13A result in chorea-acanthocytosis (ChAc), an ultrarare neurodegenerative disease [70,71,72] affecting less than 1–5 individuals per 1 million [73]. This evidence concerns the gene VPS13A and chorea-acanthocytosis.